Business Standard

Emcure Pharmaceuticals Ltd News

Emcure Pharma lists at 31% premium; should you buy, sell or hold the stock?

Emcure Pharmaceuticals listing today: According to analysts, Emcure Pharma is quoting at a reasonable valuation with a niche opportunity to invest in the gynaecology & HIV antivirals therapeutic areas

Emcure Pharma lists at 31% premium; should you buy, sell or hold the stock?
Updated On : 10 Jul 2024 | 10:25 AM IST

Emcure Pharma listing: Stock makes solid debut on NSE, BSE with 31% premium

Emcure Pharmaceuticals listing: Stock made a strong market debut as they got listed at Rs 1,325, a 31 per cent premium over the issue price of Rs 1,008 on the NSE and BSE today

Emcure Pharma listing: Stock makes solid debut on NSE, BSE with 31% premium
Updated On : 10 Jul 2024 | 10:20 AM IST

Trading guide July 10: Nifty poised to open flat; Emcure, Bansal to list

All you need to know before market opens for trade on Wednesday: The Fed chief Jerome Powell in his testimony reiterated its stance to stick with data-based decision-making; global markets trade flat.

Trading guide July 10: Nifty poised to open flat; Emcure, Bansal to list
Updated On : 10 Jul 2024 | 7:15 AM IST